The commission
took a
stab at these complicated questions, issuing new analysis and recommendations for how to manage these increasingly complex issues in medicine,
research and with direct - to - consumer tests that allow a patient to send in a cheek swab and get health information (like the personalized genome services kit offered by 23andMe, that was recently blocked by the U.S. Food and Drug Administration).